Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two strategies to reduce costs of robotic-assisted surgery in benign gynaecological cases: a German model for intraoperative cost minimisation and counteracting the shortage of physicians.

Journal of robotic surgery·2026
Same author

Age and outcomes in people with type 2 diabetes admitted to hospital with COVID-19: A cohort study.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same author

A global initiative to deliver precision health in diabetes.

Nature medicine·2024
Same author

Association between glucose dips and the feeling of hunger in a dietary intervention study among students with early and late chronotype-secondary analysis of a randomized cross-over nutrition trial.

Appetite·2024
Same author

Corrigendum: Incidence, prevalence and care of type 1 diabetes in children and adolescents in Germany: Time trends and regional socioeconomic situation.

Journal of health monitoring·2023
Same author

Incidence and presentation of new-onset type 1 diabetes in children and adolescents from Germany during the COVID-19 pandemic 2020 and 2021: Current data from the DPV Registry.

Diabetes research and clinical practice·2023
Same journal

A systematic review on the role of diet in managing pre-existing diabetes during pregnancy.

Diabetes research and clinical practice·2026
Same journal

Effects of garlic supplementation on glycemic indices in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.

Diabetes research and clinical practice·2026
Same journal

Consensus recommendations on lipohypertrophy: insights from an international panel of experts.

Diabetes research and clinical practice·2026
Same journal

Cognitive frailty in diabetic patients: A visual analysis based on CiteSpace.

Diabetes research and clinical practice·2026
Same journal

Prevalence, incidence, and 6-years stability of metabolically unhealthy normal weight́s phenotype in u.s. hispanic/latino adults.

Diabetes research and clinical practice·2026
Same journal

Corrigendum to "Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 study" [Diabetes Res. Clin. Pract. 222 (2025) 112071].

Diabetes research and clinical practice·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
10:35

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

Published on: April 6, 2022

2.7K

Diabetes in Europe: an update.

T Tamayo1, J Rosenbauer1, S H Wild2

  • 1Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Diabetes Research and Clinical Practice
|December 5, 2013
PubMed
Summary
This summary is machine-generated.

Diabetes prevalence is rising in Europe, impacting millions and increasing healthcare costs. Addressing modifiable risk factors and improving diabetes management are crucial for public health in the region.

Keywords:
DiabetesIDF Diabetes AtlasIDF Europe RegionPrevalenceRisk factors

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

15.0K

Related Experiment Videos

Last Updated: May 5, 2026

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
10:35

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

Published on: April 6, 2022

2.7K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

15.0K

Area of Science:

  • Public Health
  • Epidemiology
  • Endocrinology

Background:

  • Diabetes is a leading cause of death in the IDF Europe Region (EUR), with significant disability and healthcare costs.
  • In 2013, an estimated 56 million people had diabetes in EUR, representing an 8.5% prevalence, with wide country variations.

Purpose of the Study:

  • To analyze diabetes prevalence, trends, and risk factors in the IDF Europe Region.
  • To highlight challenges in diabetes management and suggest strategies for improvement.

Main Methods:

  • Data synthesis from existing epidemiological studies and registries within the IDF Europe Region.
  • Analysis of prevalence estimates, trends, and risk factor distributions across diverse European countries.

Main Results:

  • Diabetes prevalence varied significantly across EUR countries in 2013, from 2.4% in Moldova to 14.9% in Turkey.
  • A projected increase of nearly 10 million diabetes cases by 2035 in EUR.
  • Type 1 diabetes incidence in children (0-14 years) has also risen, with 129,350 cases in 2013.

Conclusions:

  • Modifiable risk factors like obesity, inactivity, and smoking require targeted interventions to reduce type 2 diabetes incidence.
  • Enhanced professional networking, patient empowerment, and quality monitoring are essential for effective diabetes management in Europe.